GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.
Luxury fashion and lifestyle group Kering, pharma giant GSK and building materials producer Holcim have become the first ...
Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...
GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments.
The KSE-100 index of Pakistan Stock Exchange (PSX) lost on Tuesday more than 400 points, weighed down by institutional profit ...
Copyright 2024 Alliance News Ltd. All Rights Reserved.
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
Global demand for menopause supplements is set to soar at 5.7% CAGR over the forecast period. North America is projected to ...
The global glucosamine supplement market is projected to grow from USD 583.6 million in 2023 to USD 932.7 million by 2033, expanding at a CAGR of 4.8%, according to Future Market Insights. The rising ...
Cipla is expected to report a net standalone profit of Rs 1,247 crore, according to Bloomberg estimates. The company is ...
With a torrent of top corporate earnings reports streaming in to boot, the overnight focus was on Google-parent Alphabet's ...